SMALL SUPERNUMERARY MARKER CHROMOSOMES- sSMC 15 -
|
In general 70% of sSMC carriers are clinically normal. The figures here
are based on the bias, that mainly clinically aberrant cases are reported in literature!
UPD (uniparental disomy) cases: UPD 15 maternal paternal unclear
PATIENTINFORMATION for sSMC(15)
the probably non-dosage sensitive pericentric region of chromosome 15
SCHEMATIC CYTOGENETIC DEPICTION
DISCLAIMER
SCHEMATIC MOLECULARGENETIC DEPICTION
acc. to UCSC Genome Browser on Human Mar. 2006 assembly [UCSC hg18, 2006]
and available BAC-data/ array-data from cases marked *** mentioned below [MB]
[p-tel --- centromere 18.40] uncritical region 21.18 --- 22.80 critical region
Below adapted for UCSC hg19, 2009
[p-tel --- centromere 20.70] uncritical region 23.70 --- 25.25 critical region
Clinical symptoms of centromere-near proximal imbalances
|
chromosomal region |
15pter to 15q12 |
15pter to 15q14 |
|
symptoms |
||
|
autism |
0 % | 43 % |
|
dysmorphic face |
18 % | 6 % |
|
growth retardation |
3 % | 3 % |
|
heart defect |
1 % | 1 % |
|
hypermelanosis Ito |
0 % | 3 % |
|
hypotonia |
7 % | 5 % |
|
macrocephaly |
1 % | 0 % |
|
mental retardation |
95 % | 100 % |
|
microcephaly |
0 % | 2 % |
|
seizures |
7 % | 38 % |
| number of cases | 74 | 151 |
Cases without clinical findings (O)
Cases with clinical findings (W)
Cases with unclear clinical correlation (U)
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result grade of mosaicism |
final result of the sSMC | test methods |
clinical symptoms | reference | ||
| 15-U- 1 |
female/ prenatal |
PBL | n.a. | 47,XX,+mar[20] | der(15)(p13→q?13::q? 13 or q?→q? or q?13) |
M-FISH; cenM | n.a. | {3} case 8 {4} case 8 |
||
| 15-U- 2 |
female/ at birth |
PBL | maternal | 47,XX,-14,+t(14;21)(p11;p11), +mar[?] |
inv dup(15)(q11.2 or q12) | radioactive ISH with pML34 | Down-Syndrome | {8; 9; 10} | ||
| 15-U- 2a |
male/ 1m |
PBL | de novo | 48,XY,+21,+mar[22] | inv dup(15)(q10) | cenM; subcenM |
Down-Syndrome | {1} case 23 | ||
| 15-U- 3 |
female/ 4m |
PBL | de novo | 47,XX,dup(15)(q11q13), +mar[100] | inv dup(15)(q11~12)* | wcp15; various YACS from 15q11 to 15q13 | see below | {109} | ||
| birth weight 3540g (<90. centile), spasmus nutans, developmental delay, at 4y weight >97. centile, height normal, HC 75. centile | ||||||||||
| 15-U- 4 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[20] | r(15)(::q10q1?4::) .ish(UBE3A+;SNRPN+) | M-FISH; acro-cenM; subcenM; MCB |
see below | {0} provided by Dr. A. Dufke, Tübingen, Germany | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities, pregnancy terminated; presence of marker confirmed in fetal tissue | ||||||||||
| 15-U- 5 |
male/ prenatal |
AF | de novo | 47,XY,+mar[30%]/ 46,XY[70%] |
r(15)(::p11.1→q11.1: :q11.2→q13: :q13→q11.2: :q11.1→p11.1::) .ish(D15S10-;SNRPN++) |
cenM; subcenM; SNRPN; D15S10; UPD-test |
Amniocentesis due to advanced maternal age; no ultrasound abnormalities | {0}provided by Dr. H. Heilbronner, (Stuttgart, Germany) | ||
| 15-U- 6 |
male/ prenatal |
AF | de novo | 47,XY,+mar[100%] | dic(15;22)(15q11.1;22q22.1) | cep 14/22; cep 15; characterization of #22 by p-arm polymorphism analysis | see below | {30} case 1 | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities; pregnancy terminated; autopsy revealed a normal fetus | ||||||||||
| 15-U- 8-1 to 8-3 |
male/ female 2x / prenatal |
AF | de novo | 47,+mar[100%] | inv dup(15)(q11) | all available centromeric probes | see below | {35} cases 19-21 | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities; pregnancy terminated; no abnormalities in autopsy | ||||||||||
| 15-U- 8-4 |
female/ 7y |
PBL | de novo | 47,XX,+mar[56%] 46,XY[44%] |
inv dup(15)(q11.1) | centromeric probes; subcenM | see below | {0} provided by Dr. M. Zankl, Homburg, Germany |
||
| normal size, weight and facial appearance at 7y; logopaedia since 3 y for some pronunciation problems, at 7y ataxia, no mental retardation | ||||||||||
| 15-U- 9 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | inv dup(15)(q12 or 13) | all available centromeric probes; wcp 15 | see below | {35} case 22 | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities; pregnancy terminated; no abnormalities in autopsy | ||||||||||
| 15-U- 10 |
male/ prenatal |
AF | de novo | 47,XY,+mar[100%] | der(15)t(Y;15)(q12;q22) | all available centromeric probes; wcp 15 | see below | {36} case 8 | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities; pregnancy terminated; no autopsy | ||||||||||
| 15-U- 11 |
male/ prenatal |
AF | de novo | 47,XY,+r[10]/ 46,XY[24] |
min(15) .ish(D15Z1+;wcp15+) | cep 15; SKY; SNRPN; D15S10 |
see below | {38} | ||
| Amniocentesis due to advanced maternal age; no ultrasound abnormalities; pregnancy terminated | ||||||||||
| 15-U- 12 |
female/ 8m |
PBL | de novo | 47,XX,der(1)t(1;15)(pter;q1?2), +inv dup(15)(q11)[60%]/ 46,XX,der(1)t(1;15) (pter;q1?2)[40%] |
n.a. | n.a. | see below | {66} | ||
| hypotonia, mild plagiocephaly, low-set ears, bilateral clinodactyly of 5. finger, developmentally and mentally retarded | ||||||||||
| 15-U- 13 |
female/ 6m |
PBL | de novo | 47,XX,dup(15)(q11.2q12), +inv dup(15)(q11.1)[100] | n.a. | n.a. | see below | {131} | ||
| birth weight 3700g , at 6m hypotonia, motor delay, developmental delay; dysmorphic face | ||||||||||
| 15-U- 14 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup (15)(q11.1) | cep probes and subcenM-FISH | pregnancy loss | {0} provided by Jason Anderson, (Brisbane, Australia | ||
| 15-U- 15 |
female/ prenatal |
AF | maternal balanced t(15;16) | 47,XX,+mar[100%] | der(15)t(15;16)(q13;p13.2) | wcp probes | see below | {146} | ||
| 6mm nuchal translucency in week 13+; at week 23: hydrops fetalis, micrognathia, distal limb abnormalities, two-vessel umbilical cord, Polyhydramnion; TOP in week 27; autopsy also detected flat face, hypertelorism, incomplete separation of maxillae and mandible, ascites. | ||||||||||
| 15-U- 16 to 18 |
female/ n.a. |
n.a. | 1 de novo 2 n.a. |
47,XX,+mar [100%] 2x 48,XX,+mar[?]/47,XX,+mar[?] 1x |
inv dup (15)(q11.2) (no SNRPN) |
cep 15; SNRPN |
n.a. | {148} cases 13, 16, 18 | ||
| 15-U- 19 |
female/ n.a. |
n.a. | n.a. | 48,XX,+?rx2[?]/ 47,XX,+?r[?]/ 46,XX |
?r(15) (no SNRPN) |
cep 15; SNRPN |
n.a. | {148} case 19 | ||
| 15-U- 20 |
female/ n.a. |
n.a. | n.a. | 47,XX,+mar[100%] | min(15)(pter→q12:)* (with 1 SNRPN) |
cep 15; SNRPN |
n.a. | {148} case 20 | ||
| 15-U- 20a |
female/ prenatal |
AF | n.a. | 47,XX,+mar[29]/ 46,XX[27] |
min(15)(pter→q12:) (with 1 UBE3A) |
acro-cenM, subcenM;UBE3A | advanced maternal age, TOP | {0} provided by Dr. Ana Barreta, Portugal |
||
| 15-U- 21 |
female/ prenatal |
n.a. | n.a. | 47,XX,+mar[mos] | inv dup (15) | SKY | termination of pregnancy | {153} | ||
| 15-U- 22 |
n.a./ prenatal |
n.a. | de novo | 47,+mar[100%] | inv dup (15) | centromeric probes | termination of pregnancy | {157} case 1 | ||
| 15-U- 24 |
female/ prenatal (EKF- cellbank) |
AF | de novo | 47,XX,+mar[35%]/ 46,XX[65%] |
min(15)(:p11.1→q11.1:) | cenM, acro-cenM, subcenM; UPD-test | see below | {0} provided by Dr. Mehnert, Neu-Ulm, Germany | ||
| Advanced maternal age and antibiotics therapy in month two of pregnancy due to Lyme disease; no ultrasound abnormalities; child born; normal apart from skin abnormality described as marbling of right upper body including arms plus left leg | ||||||||||
| 15-U- 25 |
see mult 2-17 | {0} provided by Dr. A Dufke, Tübingen, Germany | ||||||||
| 15-U- 26 |
male/ prenatal |
AF | de novo | 47,XY,+mar[54]/ 46,XY[8] |
min(15)(pter→q12:) , p-arm very short array: 0.00-30.61 MB min(15)(pter→q13.2:) |
midi; array-CGH | advanced maternal age, no further info available | {0} provided by Dr. Kerber, Hamburg, Germany | ||
| 15-U- 27 |
male/ prenatal |
AF | de novo | 47,XY,+mar[?%]/ 46,XY[?%] |
inv dup(15)(q10) | midi; array-CGH | no data available on embryo, studied due to high risk due to AFP | {256} case 15 | ||
| 15-U- 28 |
female/ prenatal |
AF | de novo | 47,XX,+mar[~60%]/ 46,XX[~40%%] |
inv dup(15)(:p11.2→q11.1: :q11.1→p11.2:)[6]/ inv dup(15)(:p11.1→q11.1: :q11.1→p11.1:)[1]/ min(15)(:p11.2→q11.1:)[1] |
centromeric probes, subcenM | no data available | {0}provided by Carme Fuster, Barcelona, Spain | ||
| 15-U- 29 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | inv dup(15)(q11.2) | centromeric probes, subcenM | no data available | {0} provided by Dr. Joris Vermeesch, Leuven, Belgium | ||
| 15-U- 30 |
n.a./ prenatal |
AF | de novo | 47,+mar[?%] | inv dup(15) | n.a. | no data available | {202}1 case | ||
| 15-U- 31 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[61%]/ 46,XX[39%] |
min(15)(pter→q11.1:) | centromeric probes, subcenM, SNRPN | advanced maternal age, no further info available | {0} provided by Drs. Schulze/Schmidt, Hannover, Germany |
||
| 15-U- 32 to 43 |
male (6)/ female (6)/ prenatal or postnatal |
AF/ PBL | de novo | 47,+mar[100%] | mar(15) | wcp 15 | abnormal or normal, no clear details given | {209} cases 2-9; 11-13; 15 | ||
| 15-U- 44 to 55 |
male (2)/ female (6)/ prenatal |
AF | de novo (6x); n.a. (2x) | 47,+mar[100%] | mar(15) | wcp 15 SNRPN; UPD-test (in 6 cases) | prenatally diagnosed | {210} cases 7, 9, 11-13, 15, 17-18 | ||
| 15-U- 56 to 62 |
male (3)/ female (4)/ prenatal |
AF | de novo | 47,+mar[100%] | inv dup(15) | centromeric probes | Amniocentesis due to advanced maternal age; TOP | {12} cases 13,19, 21,25,28,31; {15} cases 44 ,-,-,-,47,46,48 | ||
| 15-U- 63 |
male/ prenatal |
AF | de novo | 47,XY,+mar[100%] | inv dup(15)(q11.2) | centromeric probes; probe pHSR | Amniocentesis due to advanced maternal age; TOP | {16} case 1 | ||
| 15-U- 64 |
male/ prenatal |
AF | de novo | 47,XY,+mar[75%]/ 46,XY[25%] |
min(15)* | centromeric probes | TOP; at autopsy fetus with low set ears | {25} case 8 | ||
| 15-U- 65 to 66 |
female/ prenatal |
AF | de novo | 47,XX,+mar[75%]/ 46,XX[25%] |
min(15) and inv dup(15) | centromeric probes | TOP; no info | {26} cases 8, 10 | ||
| 15-U- 67 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | min(15)* | centromeric probes | Amniocentesis due to advanced maternal age; TOP; no info | {32; 33; 34} cases 1 | ||
| 15-U- 68 to 69 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | inv dup(15)(q11.2) | centromeric probes | TOP; no abnormalities in autopsy | {36} cases 5-6 | ||
| 15-U- 70 to 74 |
male (2)/ female (3)/ prenatal |
AF | de novo | 47,+mar[100%] | inv dup(15)(q11.1) | centromeric probes | TOP; no abnormalities in autopsy | {15} cases 44-48 | ||
| 15-U- 75 |
n.a./ prenatal |
AF | de novo | 47,+mar[?100%] | inv dup(15) | centromeric probes | TOP; no info | {48} 1 case | ||
| 15-U- 76 |
female/ prenatal |
AF | de novo | 47,XX,+mar[?100%] | inv dup(15) | centromeric probes | no info | {51} case DL9 | ||
| 15-U- 77 |
male/ prenatal |
AF, lung, skin, tendon, gonad, blood | de novo | 48,XY,+2mar[79-95%]/ 46,XY[remainder] |
inv dup(15) | centromeric probes | TOP; no abnormalities in autopsy | {65} case 2 | ||
| 15-U- 78 to 80 |
female (2x)/1x n.a./ prenatal |
AF | n.a. | 47,+mar[?100%] | inv dup(15) | centromeric probes | TOP and or no info available | {71} cases 9/11/22 {102} cases 16/11/-- |
||
| 15-U- 81 to 83 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?100%] | inv dup(15) | centromeric probes | no info available | {84} cases 1-3 | ||
| 15-U- 84 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?100%] | mar(15) | centromeric probes | no info available | {125} case HS38 | ||
| 15-U- 85 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?100%] | mar(15) | centromeric probes | no info available | {130} | ||
| 15-U- 86 |
male/ prenatal |
AF | n.a. | 48,XY,+mar,+mar[100%] | inv dup(15)(q10)x2 | cenM, subcenM; UPD-test | no info available | {0} provided by Dr. Sanding, Leipzig, Germany | ||
| 15-U- 87 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.1) | cenM, subcenM | no info available | {0} provided by Dr. M. Manolakos, Athens, Greece | ||
| 15-U- 88 to 132 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | mar(15) | n.a. | no info available | {212} 45 cases | ||
| 15-U- 133 |
male/ 11y |
PBL | de novo | 47,XY,+mar[100%] | inv dup(15)(q12) deletion in Williams Beuren syndrome critical region on 7q11.2 |
centromeric probe; Williams Beuren syndrome probe |
see below | {218} | ||
| Williams Beuren syndrome; at birth: talus valgus pronate feet, gastroesophagial reflux, hypotonia, feeding problems; later: systemic hypertension, weight and height below 3rd centile, psychomotor delay, supravalvular and aortic stenosis, | ||||||||||
| 15-U- 134 |
male/ prenatal |
AF | de novo | 47,XY,+mar[15]/ 46,XY[15] |
inv dup(15)(q12) | centromeric probes | sSMC detected due to amniocentesis in connection with advanced maternal age; no further info available | {227} | ||
| 15-U- 135 to 136 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | mar(15) | centromeric probes | no info available | {228}2 cases | ||
| 15-U- 137 to 142 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | inv dup(15) | centromeric probes; BACs | no info available | {233}6 cases | ||
| 15-U- 143 to 150 |
n.a./ prenatal |
AF | n.a. | 47,+mar[?%] | mar(15) | SKY | no info available | {236} 8 new cases | ||
| 15-U- 151 |
n.a./ n.a |
n.a. | n.a. | 47,+mar[?%] | mar(15) | midi | no info available | {245} 1 case | ||
| 15-U- 152 |
female/ prenatal |
AF | de novo | 47,XX,+mar[10]/ 46,XX[5] |
min(15)(pter→q11.2:) 0.00-20.94 MB |
midi; cep probes; array-CGH | advanced maternal age; no info available | {0} | ||
| 15-U- 153 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.1) | cenM; subcenM | advanced maternal age; no info available | {0} provided by genetikaimd, Belgrade, Serbia | ||
| 15-U- 154 to 159 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | mar(15) | wcp probes | no info available | {258} 6 cases | ||
| 15-U- 160 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | mar(15;16) | wcp probes | no info available | {258} 1 case | ||
| 15-U- 161 |
female/ 2y |
PBL | n.a. | 47,XX,+mar[16]/ 46,XX[14] |
inv dup(13;15)(p11.2p11.2) | cep probes | moderate psychomotor retardation, slight dysmorphic features. | {259} first case | ||
| 15-U- 162 |
n.a./ prenatal |
AF | n.a. | 47,+mar[?%] | inv dup(15)(q1?) | n.a. | advanced maternal age; no info available | {260} | ||
| 15-U- 163 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | inv dup(15)(q14) | cenM, subcenM, SNRPN | advanced maternal age, twin pregnancy; selective TOP of twin with sSMC | {0} provided by Dr. Demuth, Erfurt, Germany | ||
| 15-U- 164 |
male/ newborn |
PBL | de novo | 48,XY,+inv dup(15), +18[100%] | n.a. | n.a. | trisomy 18 pheontype | {265} | ||
| 15-U- 165 |
n.a./ prenatal |
AF | de novo | 47,+mar[100%] | inv dup(15) | cep 15, wcp 15 | advanced maternal age, TOP | {270} case 1 | ||
| 15-U- 166 |
n.a./ prenatal |
AF | n.a. | 47,+mar[?%] | mar(15) | n.a. | n.a. | {274} 1 case | ||
| 15-U- 167 |
female/ prenatal |
PBL | n.a. | 47,XX,+mar[27]/ 46,XX[3] |
inv dup(15)(q11.2) Array: 0.00-21.38 MB |
cep probes; subcenM; array-CGH; UPD-test | advanced maternal age - no follow up available | {0} provided by J Melo, Coimbra, Portugal | ||
| 15-U- 168 |
male/ prenatal |
AF | n.a. | 48,XY,+marx2[3]/ 47,XY,+mar(24)/ 46,XY[3] |
inv dup(15)(q11.1) | acrocenM, subcenM | born after unsuccessful fetocide; mental and growth retardation, asphyxia perinatal and with no minor stigmata. | {0} provided by gentikaimd, Serbia | ||
| 15-U- 169 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[100%] | inv dup(15)(q11.1) | cenM, subcenM; UPD-test | advanced maternal age - no follow up available | {0} provided by Dr. Huhle, Wetzlar, Germany | ||
| 15-U- 170 |
male/ n.a. |
n.a. | n.a. | 47,XY,+mar[100%] | inv dup(15)(q13~14) | cep probes, subcenM, MCB | n.a. | {0} provided by J Melo, Coimbra, Portugal | ||
| 15-U- 171 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[100%] | r(15)(::p1?2→q11.1::) | cep probes, subcenM | TOP - no info available | {0} provided by Dr. C. Fuster, Spain | ||
| 15-U- 172 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[100%] | inv dup(15)(q11.1) | cep probes, subcenM | n.a. | {0} provided by J Melo, Coimbra, Portugal | ||
| 15-U- 173 |
n.a./ prenatal |
AF | n.a. | 47,+mar[?%] | inv dup(15) | n.a. | n.a. | {283} | ||
| 15-U- 174 to 188 |
n.a./ prenatal |
AF | de novo | 47,+mar[?%] | inv dup(15) | n.a.; UPD-test | n.a. | {290} 15 cases | ||
| 15-U- 189 |
female/ prenatal |
AF | maternal (bal. transloc.) | 47,XX,+mar[100%] | der(15)t(9;15)(p12;q14) | MLPA: wcps | ascites, advanced maternal age | {300} case 14 | ||
| 15-U- 190 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11) | cep probes, MLPA: wcps | advanced maternal age | {300} case 15 | ||
| 15-U- 191 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[54]/ 46,XX[5] |
inv dup(15)(q11.2) | cenM, subcenM; LSI UBE3A; UPD-test | advanced maternal age | {0} provided by Dr. Meins, Hannover, Germany | ||
| 15-U- 192 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[21]/ 46,XY[54] |
min(15)(pter→q11.1:) | cenM, subcenM; LSI UBE3A | short femur in sonography, no follow up available | {0} provided by Dr. Huzhle, Leipzig, Germany | ||
| 15-U- 193 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[21]/ 46,XX[8] |
inv dup(15)(q11.1) | acrocenM, subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. Kozlowski, Düsseldorf Germany | ||
| 15-U- 194 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[31]/ 46,XY[19] |
min(15)(pter→q11.1:) | acrocenM, subcenM; UPD-test | advanced maternal age - no follow up available | {0} provided by Dr. Snezana, Belgrade, Serbia | ||
| 15-U- 195 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.1) | acrocenM, subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. Zivi Borochowitz; Israel | ||
| 15-U- 196 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[50%]/ 46,XX[50%] |
inv dup(15)(q11.1) | acrocenM, subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. Kozlowski, Düsseldorf Germany | ||
| 15-U- 197 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.2) | acrocenM, subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. S. Ourru, Cagliari, Italy | ||
| 15-U- 198 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.2) | acrocenM, subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. S. Ourru, Cagliari, Italy | ||
| 15-U- 199 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[11]/ 46,XY[5] |
inv dup(15)(q11.1) | ceps; subcenM; | advanced maternal age - no follow up available | {0} provided by Dr. Beudt, Frankfurt, Germany | ||
| 15-U- 200 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[2]/ 46,XY[23] |
min(15)(pter→q11.1:) | cenM, subcenM | advanced maternal age - no follow up available | {0} provided by Dr. Heilbronner, Stuttgart, Germany | ||
| 15-U- 201 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[100%] | inv dup(15)(q11.1) | acrocenM, subcenM | advanced maternal age - no follow up available | {0} provided by Dr. D. Katarska Slovakia | ||
| 15-U- 202 |
male/ prenatal |
AF | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.1) | acrocenM, subcenM | advanced maternal age - no follow up available | {0} provided by Dr. M.B. Petersen, Athens, Greece | ||
| 15-U- 202a |
n.a./ prenatal |
AF | n.a. | 47,XN,+mar[100%] | inv dup(15)(q11.1) | acrocenM, subcenM | n.a. | {0} provided by Mikrogen, Turkey |
||
| 15-U- 202b |
female/ 6y |
PBL | n.a. | 47,XX,+mar[100%] | inv dup(15)(q11.1) | array-CGH | seizures, hypotonia, DD, no speach | {309} case 2 | ||
| 15-U- 202c |
male/ 10y |
PBL | n.a. | 47,XY,+mar[100%] | inv dup(15)(q11.1) | acrocenM, subcenM | abnormal | {0} provided by Dr. M. Mulhatino, Rio de Janeiro, Brasil |
||
| 15-U- 203 |
female/ 3y |
PBL | n.a. | 47,XX,+mar[?100%] | inv dup(15) | SKY | n.a. | {311} case F0642559 | ||
| 15-U- 204 |
female/ 6y |
PBL | n.a. | 47,XY,+mar[?100%] | inv dup(15) | SKY | Pervasive developmental disorder | {311} case F0658799 | ||
| 15-U- 205 |
male/ 45y |
PBL | n.a. | 47,XY,+mar[100%] | der(15)t(15;18)(q11.1;p11.1~11.21) | midi, rev FISH | severe osteoporosis and feminine body, fertile | {0} provided by Dr. Eunice-Georgia G. Stefanou, Patras Greece | ||
| 15-U- 206 |
male/ newborn |
PBL | mat | 47,XY,+mar[100%] | der(15)t(15;16)(q13;q13) | SKY | microcephaly, dysmporphic features, tetralogy fallot, child dies with 11 months | {312} | ||
| 15-U- 207 |
female/ 6y |
PBL | mat; grandpat | 47,XX,+mar[100%] | der(15)t(15;16)(q13;p13.2) | wcp FISH and aCGH | dysmporphic features, micorsomia, hearing and speech impairment | {313} | ||
Cases with an inv dup(15) or min(15) and autism -
without listing extensive clinical details on the cases in this summary (Caw)
| case no. | sSMC shape | reference | ||
| 15-Caw-1 | 1x inv dup | {75} | ||
| 15-Caw-2 | 1x "inv dup" | {76} case J.C. | ||
| 15-Caw-3 | 1x inv dup | {78; 79} (with Angelman syndrome) | ||
| 15-Caw-4 to 15-Caw-31 | 28x inv dup | {80} 28 cases | ||
| 15-Caw-32 | 1x inv dup | {81} | ||
| 15-Caw-33 to 15-Caw-34 | 2x inv dup | {82} case JB = {101} case 1 = {102} case 4; {82} case MB = {102} case 19 |
||
| 15-Caw-35 to 15-Caw-36 | 1x inv dup, 1x min | {83} cases a and b | ||
| 15-Caw-37 | 1x inv dup | {85} | ||
| 15-Caw-39 | 1x inv dup | {89} | ||
| 15-Caw-40 to 15-Caw-45 | 6x inv dup | {90} cases A-F; {120} cases B; C; D; F | ||
| 15-Caw-46 | 1x inv dup | {91} | ||
| 15-Caw-47 | 1x inv dup | {94} | ||
| 15-Caw-48 | 1x inv dup (?) | {105} case 8 | ||
| 15-Caw-49 | 1x inv dup | {71} case 26 | ||
| 15-Caw-50 | 1x inv dup | {154} | ||
| 15-Caw-51 | 1x inv dup | {156} | ||
| 15-Caw-52 | 1x min (?) | {169}case B | ||
| 15-Caw-53 to 15-Caw-54 | 3x inv dup |
{196} 2 cases |
||
| 15-Caw-55 | 1x inv dup |
{0} 1 case provided by Dr. H. Nelle, Jena, Germany |
||
| 15-Caw-56 | 1x inv dup |
{220} |
||
| 15-Caw-57 | 1x inv dup |
{295} |
||
| 15-Caw-58 | 1x inv dup |
{0} 1 case provided by Dr. Petersen, Athens, Greece |
||
| 15-Caw-58 | 1x inv dup | {309} case 1 | ||
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result grade of mosaicism |
final result of the sSMC | test methods |
clinical symptoms | reference | ||
| 15-Caw- special case 1 |
male/ 1y |
PBL | de novo | 47,XY,+mar[100%?] | inv dup(15)(q11.2) + Necdin, Makorin, MAGEL2 and NECDIN encoding region and BACs for the SNURF SNRPN-UBE3A region duplicated on one 'normal' chromosome 15 |
centromeric probes; SNRPN and other probes |
see below | {158} | ||
|
behavioural problems at age 29 months. at 36 months, stereotypical play and using fewer than 6 words. At 48 months he met ADI/ADOS criteria for autistic disorder. Overall IQ (Stanford Binet) was 92, with relative strength in abstract/visual and quantitative reasoning, and weakness in verbal reasoning. The child is somewhat obese and has cupped pinna but is not otherwise noted to be dysmorphic. |
||||||||||
| 15-Caw- special case 2 |
male/ 6y |
PBL | de novo | 47,XY,+mar[100%?] | inv dup(15)(q14) | centromeric probes; D15Z1; SNRPN; D15S10; PML |
developmental delay, microcephaly, autistic behaviour | {0} provided by A. Dufke, Göttingen, Germany |
||
| 15-Caw- special case 3 |
male/ 8y |
PBL | de novo | 47,XY,+mar[100%?] | inv dup(15)(q13.1) array: 0.00-25.93 MB |
cenM, subcenM, midi; UPD-test |
at 8 years: Severe psychomotor development delay; speech problems, no control of sphincters, growth delay, autism and hyper-reactivity, frontal lobe epilepsy | {0} provided by Joana Melo, Coimbra, Portugal | ||
| 15-Caw- special case 4 |
female/ 5y |
PBL | maternal | 47,XX,+mar[100%] | inv dup(15)(q13.1) array: 0.00-25.93 MB array mother: 0.00-25.93 MB |
cenM, subcenM; array-CGH | see below | {0} provided by Dr. I Marques Carreiras and J. Melo, Coimbra, Portugal | ||
|
Mental retardation; autism; hypotonia; speech problems; Mother at 27 years: Low IQ; Learning disabilities |
||||||||||
Cases with an inv dup(15) and seizures -
without listing extensive clinical details on the cases in this summary (Csw)
| case no. | sSMC shape | reference | ||
| 15-Csw-1 to 15-Csw-5 | abnormal phenotype; 5x inv dup - q13 involved |
{187} 5 cases |
||
| 15-Csw-6 to 15-Csw-9 | abnormal phenotype; 4x inv dup - q13 involved |
{44} 4 cases |
||
| 15-Csw-10 | abnormal phenotype; 1x inv dup |
{135} |
||
| 15-Csw-11 to 15-Csw-15 | abnormal phenotype; 7x inv dup |
{189} 7 cases |
||
| 15-Csw-16 | abnormal phenotype; inv dup - q13 involved |
{190} |
||
| 15-Csw-17 to 15-Csw-23 | abnormal phenotype; 7x inv dup - q13 involved |
{63} cases 1, 3, 4, 5, 6, 7, 8 |
||
| 15-Csw-24 to 15-Csw-25 | abnormal phenotype; 2x inv dup |
{191} cases 3 and 7 |
||
| 15-Csw-26 | abnormal phenotype; inv dup - q13 involved |
{188} case 1449 |
||
| 15-Csw-27 | abnormal phenotype; inv dup - q13 involved |
{192} |
||
| 15-Csw-28 to 15-Csw-29 | abnormal phenotype; 2x inv dup - q13 involved |
{193} 2 cases |
||
| 15-Csw-30 | abnormal phenotype; inv dup |
{194} |
||
| 15-Csw-31 | abnormal phenotype; inv dup |
{195} |
||
| 15-Csw-32 to 15-Csw-34 | abnormal phenotype; 3x inv dup |
{196} 3 cases |
||
| 15-Csw-35 | abnormal phenotype; inv dup |
{119} |
||
| 15-Csw-36 | abnormal phenotype; inv dup |
{1} case 22, {2} |
||
| 15-Csw-37 | abnormal phenotype; inv dup |
{14} case 2 |
||
| 15-Csw-38 to 15-Csw-39 | abnormal phenotype; 2x inv dup |
{123} case C, E |
||
| 15-Csw-40 | abnormal phenotype; inv dup |
{151} |
||
| 15-Csw-41 | abnormal phenotype; inv dup |
{113} |
||
| 15-Csw-42 | abnormal phenotype; inv dup |
{305} |
||
Cases with an sSMC and Prader Willi Syndrome (P)
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result grade of mosaicism |
final result of the sSMC | test methods |
clinical symptoms | reference | ||
| 15-P- 1 |
male/ 5y |
PBL | de novo | 47,XY,+r(?)[70%]/ 46,XY[30%] |
r(15); no PWS-region on ring and del of PWS on one normal chr. 15; no UPD 15 |
different FISH probes: (cep 15; wcp 15); UPD-test | Prader Willi syndrome | {17} case 1 | ||
| 15-P- 2 |
female/ 9m |
PBL | de novo | 47,XX,+r(?)[50%]/ 46,XX[50%] |
mar(X) mat UPD 15 |
different FISH probes: (wcp X); UPD-test |
Prader Willi syndrome | {17} case 2 | ||
| 15-P- 3 |
female/ postnatal |
PBL | n.a. | 47,XX,+mar[25%]/ 46,XX[75%] |
mar(15).ish (15Z1+,pTRA-25+,D15S18-) mat UPD 15 heterodisomy |
different FISH probes: (wcp 15, cep 15 - see left field); UPD-test |
Prader Willi syndrome | {257} 1 case | ||
| 15-P- 4 |
n.a./ postnatal |
PBL | n.a. | 47,+mar[8%]/ 46[92%] |
inv dup(15) maternal UPD 15 |
molecular genetics; UPD-test | Prader Willi syndrome | {294} | ||
| 15-P- 5 |
male/ 6y |
PBL | de novo | 47,XY,+mar[46]/ 46,XY[54] |
inv dup(22)(q11.1) maternal UPD 15 |
cep probes; UPD-test | PWS | {304} | ||
| 15-P- q1?/ 1-1 |
female/ 35y |
PBL | de novo | 47,XX,+min(15)(q1?)[60%]/ 46,XX[40%]* |
n.a. | n.a. | Prader Willi syndrome | {68} | ||
| 15-P- q11/ 1-1 |
female/ n.a. |
PBL | de novo | 47,XX,+inv dup(15)(q11)[80%]/ 46,XX[20%] |
n.a. | n.a. | Prader Willi syndrome | {18} | ||
| 15-P- q11/ 1-2 |
male/ 12y |
PBL | de novo | 47,XY,+inv dup(15)(q11)[70%]/ 46,XY[30%] |
n.a. maternal UPD 15 |
n.a.; UPD-test | Prader Willi syndrome | {19} case 2 | ||
| 15-P- q11/ 1-3 |
female/ 3y |
PBL | de novo | 47,XX,+inv dup(15)(q11)[100%] | n.a. | n.a.; | Prader Willi syndrome | {23} | ||
| 15-P- q11/ 1-4 |
male/ 26y |
PBL | de novo | 47,XY,+inv dup(15)(q11)[100]* | inv dup (15)(q11) maternal UPD 15 |
n.a.; UPD-test | Prader Willi syndrome | {45; 46} | ||
| 15-P- q11/ 1-5 |
male/ 33y |
PBL | de novo | 47,XY,+inv dup(15)(q11)[24]/ 46,XY[29] |
inv dup (15)(q11) maternal UPD 15 |
centromeric probe 15 and 6 single copy probes from 15q11 to 15q13; UPD-test | Prader Willi syndrome | {47} case WJK303 | ||
| 15-P- q11/ 1-6 |
male/ 17y |
PBL | de novo | 47,XY,+inv dup(15)(q11~q12) | n.a. | n.a. | Prader Willi syndrome | {64} | ||
| 15-P- q11/ 1-7 |
female/ 18y |
PBL | de novo | 47,XX,+inv dup(15)(q11~q12)[41]/46,XX[59] | n.a. | n.a. | Prader Willi syndrome | {140} | ||
| 15-P- q11/ 1-8 |
female/ 17y |
PBL | de novo | 47,XX,+inv dup(15)(q11)*[100%] | n.a. | n.a. | Prader Willi syndrome | {59} | ||
| 15-P- q11/ 1-9 |
male/ 16m |
PBL | de novo | 47,XY,+inv dup(15)(q11)[100%] | n.a. | n.a. | Prader Willi syndrome | {72} case 9 | ||
| 15-P- q11/ 1-10 |
male/ 2y8m |
PBL | de novo | 47,XY,+inv dup(15)(q11)[30]/ 46,XY[10] |
n.a. | n.a. | Prader Willi syndrome | {117} case 1 | ||
| 15-P- q11/ 1-11 |
male/ 8y |
PBL | de novo | 47,XY,+inv dup(15)(q11)[8]/ 46,XY[7] |
n.a. | n.a. | Prader Willi syndrome | {117} case 2 | ||
| 15-P- q11/ 1-12 |
male/ 2y |
PBL | de novo | 47,XY,+mar[100%] | mar(15) | CGH | Prader Willi syndrome | {43} case 3 | ||
| 15-P- q11/ 1-13 |
female/ prenatal |
PBL | de novo | 47,XX,+inv dup(15)(q11)[100%] | inv dup(15)(q11) maternal UPD 15 |
cep probes wcp 15, PWS specific probes; UPD-test | Prader Willi syndrome | {223} case 4 | ||
| 15-P- q11.1/ 1-1 |
male/ 1m |
PBL | de novo | 47,XY,+mar[70%]/ 46,XY[30%] |
min(15)(pter→q11.1:) maternal UPD 15 |
cenM; subcenM; UPD-test | Prader Willi syndrome | {168} | ||
| 15-P- q11.1/ 1-2 |
female/ 13y |
PBL | de novo | 47,XX,+mar[100%] | min(15)(pter→q11.2:) maternal UPD 15 |
cep 15; LSI SNRPN; UPD-test | Prader Willi syndrome | {147} | ||
| 15-P- q11.1/ 2-1 |
female/ 12y |
PBL | de novo | 47,XX,del(15)(q11.200→q11.207), +inv dup(15)(q11.1)[100%] | n.a. | n.a. | Prader Willi syndrome | {58} case 2 | ||
| 15-P- q11.1/ 2-2 |
female/ 1m |
PBL | de novo | 47,XX,+mar[55%]/ 46,XX[45%] |
inv dup(15)(q11.1) maternal UPD 15 |
centromeric probes; UPD-test | Prader Willi syndrome | {164} | ||
| 15-P- q11.1/ 2-3 |
n.a./ 13y |
PBL | n.a. | 47,+mar[?%]/ 46[?%] |
inv dup(15)(q11.1) no UPD 15 |
centromeric probes; UPD-test | Prader Willi syndrome due to microdeletion | {287} case 41 | ||
| 15-P- q11.1/ 2-4 to 2-5 |
n.a./ prenatal |
AF | de novo | 47,+mar[?%]/ 46[?%] |
inv dup(15)(q11.1)* maternal UPD 15 |
centromeric probes ?; UPD-test | Prader Willi syndrome | {290} 2 cases | ||
| 15-P- q11.1/ 2-6 |
male/ prenatal |
AF | de novo | 47,XY,+mar[39%]/ 46,XY[61?%] |
inv dup(15)(q11.1)* maternal UPD 15 |
centromeric probes ?; UPD-test | Prader Willi syndrome, TOP | {291} | ||
| 15-P- q11.1/ 2-7 |
female/ prenatal |
AF | n.a. | 47,XX,+mar[50%]/ 46,XX[50%] |
inv dup(15)(q11.1) maternal UPD 15 |
acrocenM, subcenM; UPD-test | advanced maternal age - pregnancy continued | {0} provided by Dr. Kozlowski, Düsseldorf Germany | ||
| 15-P- q11~ 13/ 1-1 |
male/ 29y |
PBL | de novo | 47,XY,+mar [85%]/ 46,XY[15%] |
inv dup(15)(pter→q11: :q13→pter)* maternal UPD 15 |
YAC probes as specified in {57}; UPD-test | Prader Willi syndrome | {57} case 13 | ||
| 15-P- q11~ 13/ 1-2 |
male/ 1 w |
PBL | de novo | 47,XY,+mar[16%]/ 46,XY[84%] |
r(15)(::p11.1→q11.1~q13::) maternal UPD 15 sSMC derived from paternal chromosome 15 |
all cep; SNRPN; D15Z4 ; UPD-test |
see below |
{152} | ||
|
result of an in vitro fertilization procedure; intrauterine growth retardation was detected by ultrasound; and fetal movements in the low range. Birth was induced at 35 weeks because of fetal distress. Apgar score 1 at 1 min and 8 at 5 min; birth weight 1.290 kg; generalized hypotonia both testes were palpated in the inguinal region and were surgically reduced, the penis was small. At that time he weighed 2.490 kg and the mother complained of feeding difficulties. walking at 3 years; first words at 3.5 years, excessive eating started at 3 years, his weight at 3.5 years was 18 kg (>97%) and his height was 93 cm (50%). facial appearance was typical for Prader-Will syndrome (PWS); |
||||||||||
| 15-P- q11.2/ 1-1 |
female/ 4m |
PBL/skin fibroblasts | de novo | 45,XX,trob(15;15)[34]/ 46,XX,trob(15;15),+mar1[41]/ 46,XX,trob(15;15),+mar2[2]/ 46,XX,trob(15;15),+mar1x2[0] (in fibroblasts: 60/130/8/2) |
mar1 = r(15)(::p11.1→q11.2::) mar2 = r(15;15)(::p11.1→q11.2: :p11.1→q11.2::) |
n.a. | Prader Willi syndrome | {58} | ||
| 15-P- q12/ 1-1 |
male/ 16y |
PBL/skin fibroblasts | de novo | 48,X,t(Y;15)(q21;q12), +inv dup(15)x2[2/1]/ 47,X,t(Y;15)(q21;q12), +inv dup(15)[38/5]/ 46,X,t(Y;15)(q21;q12)[41/89] |
n.a. | n.a. | Prader Willi syndrome | {24} case 1 | ||
| 15-P- q12/ 2-1 |
male/ 11.5y |
PBL | de novo | 47,XY,+min(15)(pter→q12:)[100%] | n.a. | n.a. | Prader Willi syndrome | {60} | ||
| 15-P- q12/ 2-2 |
male/ 23y |
PBL | de novo | 47,XY,+min(15)(pter→q12~3:)*[100%] | n.a. | n.a. | Prader Willi syndrome | {103} reported case | ||
| 15-P- q12/ 2-3 |
female/ 16m |
PBL | de novo | 47,XX,+mar[20%]/46,XX[80%] | inv dup(15)(q12~13) FISH-data: SNRPN at 22.8MB on sSMC maternal UPD 15 |
SNRPN; UPD-test | Prader Willi syndrome | {293} | ||
| 15-P- q21/ 1-1 |
male/ n.a. |
PBL | de novo | 47,XY,+min(15)(pter→q21:)*[100%] | n.a. | n.a. | Prader Willi syndrome | {103} personally comunicated by Lubunski | ||
Some additionally reports with SMC in PWS cases in the pre-FISH-era are available in the literature and not listed here like e.g. {22};
in {73} review of such cases before 1986 (some of them included in list above, as well).
Cases with a sSMC and Angelman phenotype (A)
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result grade of mosaicism |
final result of the sSMC | test methods |
clinical symptoms | reference | ||
| 15-A- q11/ 1-1 |
male/ 4y |
PBL | de novo | 47,XY,+inv dup(15)(q11)[60%]/ 46,XY[40%] |
n.a. paternal UPD 15 |
n.a.; UPD-test | Angelman syndrome | {19} case 1; {294} | ||
| 15-A- q11/ 1-2 |
male/ 18m |
PBL | de novo | 47,XY,+mar[50] | inv dup(15)(q11) paternal UPD 15 |
FISH with D15S63; cen15; UPD.test | Angelman syndrome | {78; 79} | ||
| 15-A- q11/ 2-1 |
female/ 14m |
PBL | de novo | 47,XX,+r[50] | r(15)(::p?→q1?1::)* del(SNRPN) on one 'normal' chromosome |
multiprobe FISH; SNRPN | Angelman syndrome | {155} | ||
| 15-A- q11.2/ 1-1 |
male/ prenatal |
AF | n.a. | culture 1: 47,XY,+mar[100] culture 2: mar only in 32% |
inv dup(15)(q11.2) Array-CGH: 0.00-21.29 MB paternal UPD 15 |
cenM; subcenM; UBE3A; array-CGH; UPD.test | Angelman syndrome | {0} provided by Dr. Thiel, Berlin, Germany | ||
| 15-A- q11 ~12/ 1-1 |
male / 2.5y |
PBL | de novo | 47,XY,del(15)(q11→q13),+mar[50] | inv dup(15)(q11~12)* | FISH with D15Z2 and GABRB3 | Angelman syndrome | {61} | ||
| 15-A- q13/ 1-1 |
male / 6y |
PBL | de novo | 47,XY,+mar[50] | inv dup(15)(q13) | FISH with D15Z2 and GABRB3 | Angelman syndrome | {20} case 1 | ||
| 15-A- q13/ 1-2 |
male / 13y |
PBL | de novo | 47,XY,+mar[50] | inv dup(15)(q13) | FISH with D15Z2 and GABRB3 | Angelman syndrome | {20} case 2 | ||
Some additionally reports with SMC in PWS cases in the pre-FISH-era are available in the literature and not listed here like e.g. {22};
in {73} review of such cases before 1986 (some of them included in list above, as well).
Cases with neocentromeres (N)
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result grade of mosaicism |
final result of the sSMC | test methods |
clinical symptoms | reference | ||
| 15-N- 1a |
see 15-N-qt23/1-2 | |||||||||
| 15-N- mar/1 |
n.a./ n.a. |
PBL? | n.a. | 47,+mar[?] | mar(15) | SKY | poor growth; developmental delay | {128} case 6 | ||
| 15-N- mar/2 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | mar(15) | wcp15; cep15 | see below | {26} case 11{244} | ||
|
multiple congenital abnormalities after birth; abnormal ultrasound findings during pregnancy |
||||||||||
| 15-N- q11.2/ 1-1 |
female/ 15y |
PBL | de novo | 47,XX,+mar[38]/ 46,XX[12] |
neo r(15)(::q11.2→q13.1: :q11.2→q13.1::) or r(15)(::q13.1→q11.2: :q11.2→q13.1::) or neo min(15)(:q13.1→q11.2: :q11.2→q13.1:) array: 18.26-22.49 MB |
M-FISH; MCB, BACs, midi, rev FISH; array-CGH; UPD-test | normal, but delayed puberty | {298} case 8 | ||
| 15-N- q11.2/ 2-1 |
female/ 15y |
PBL | de novo | 47,XX,+mar[27]/ 46,XX[2] |
neo r(15)(::q11.2→q13: :q11.2→q13::) array: 20.33-26.86 MB |
subcenM, BACs, midi, rev FISH; array-CGH | Short stature, absence of pubertal signs, Madelung deformity, slight shortening of the radius and broad "shield-like" thorax. |
{0} provided by Dr. Castedo, Porto, Portugal | ||
| 15-N- q22.1/ 1-1 |
n.a./ 15y |
PBL | de novo | 47,+mar[70%]/ 46[30%] (mar in 49% of fibroblasts) |
r(15)(::q22.1→q22.3::){175} or r(15)(::q22.2→q24.1::){224, 225, 239} |
CGH; FISH with BAC probes; M-FISH | see below | {175} case 2, {224} case 115, {225, 239; 244} | ||
|
increased postnatal growth, obesity, long fingers, facial dysmorphism; at birth in 42 week of gestation: 2550g, 53cm; weight, length and OFC <3rd centile; at 1 y: 76cm (>25centile), 9350g (>25centile), at 6y 125cm (>90centile), 29kg (>95centile); mentally normal at 21y |
||||||||||
| 15-N- q22.1/ 1-2 |
female/ prenatal |
AF | de novo | 47,XX,+mar[1]/ 47,XX,del(15)(q22) or t(15;?)(q22;?),+mar[1]/ 46,XX[30] |
inv dup(15)(qter→q22: :q22→qter) |
wcp, MCB | see below | {0} | ||
|
advanced maternal age, normal child born |
||||||||||
| 15-N- qt23/ 1-1 |
male/ 1w |
PBL/ fibroblasts | de novo | 47,XY,+mar[70%]/ 46,XY[30%] (mar in 11% of fibroblasts) |
inv dup(15)(qter→q23: :q23→qter) | all cep probes; telomeric probe; midi; specific probe in 15q26 | see below | {15} case 49; {110} case A {116; 144; 167; 244} |
||
|
uneventful pregnancy and birth; weight: 3370g, length 51cm; peculiar appearance with antimongoloid slant of palpebral fissures, epicanthic folds, low-set ears, bulbous nose, broad nasal root, retrognathia, high arched palate, long philtrum, down-turned corners of the mouth, arachnodactyly of fingers and toes, joint contractures of hips; asymmetric thorax and head, thoraco-lumbar kyphosis; delayed psychomotor development + mental retardation; at 2y 98cm height (98. percentile), bilateral sensor neural hearing loss. |
||||||||||
| 15-N- qt23/ 1-2 |
female/ 11y |
PBL (EKF- cellbank) |
de novo | 47,XX,+mar[4]/ 46,XX[46] |
inv dup(15)(qter→q24.1: :q24.1→qter) |
all wcp probes; telomeric probe; MCB | see below | {216} case 7 {234}case Neo #15-5 {244} |
||
|
Normal pregnancy and birth. At birth weight 2920g, length 49cm; craniofacial dysmorphism including cataract. Moreover hemangiomas on right forearm, abnormal feet (clasp like). At 6 months developmental delay, muscular hypotonia, spastic legs. At 3 years focal seizures (right). At 11y mental retardation, idiopathic thoracolumbal scoliosis, hip dysplasia, mitral valve prolapsed, weight: 29kg, length 152cm. Low weight in connection with feeding problems. |
||||||||||
| 15-N- qt2?4/ 1-1 |
female/ prenatal |
AF | de novo | 47,XX,+mar[100%] | inv dup(15)(qter→q2?4: :q2?4→qter) |
all available centromeric probes for the acrocentric chromosomes; MLPA | Amniocentesis due to diagnosis of Dandy-Walker syndrome in ultrasound, which was confirmed postnatally, child survived only one day. | {31} case 3 {300} case 13 |
||
| 15-N- qt24/ 1-1 |
female/ prenatal |
AF/ PBL | de novo | 47,XX,+mar[50%]/ 46,XX[50%] present in 66% of PBL; |
inv dup(15)(qter→q24: :q24→qter) | wcp15; FES; cen15; | see below | {129; 144} case 2, {180} case 10 {167; 244} |
||
|
Amniocentesis due to abnormal ultrasound findings with nuchal edema, complex heart defect, bilateral hydronephrosis; pregnancy terminated in week 24; acc. to autopsy mild intrauterine growth retardation, polycystic left kidney, dysplastic right kidney |
||||||||||
| 15-N- qt24/ 1-2 |
n.a./ n.a. |
n.a. | n.a. | 47,+mar[?%] | inv dup(15)(qter→q24: :q24→qter) | n.a. | n.a. | {261} | ||
| 15-N- qt24.1 -25.1/ 1-1 |
female/ 1w |
PBL | de novo | 47,XX,+mar[80%]/ 46,XX[20%] |
inv dup(15)(qter→q24.1: :q25.1→qter) (acc to 166) |
all cep probes; telomeric probe; midi; specific probe in 15q26 | see below | {15} case 50; {110} case B {116; 144; 167; 244} {166} case 1 |
||
|
uneventful pregnancy and birth; weight: 4510g, length 55cm; low-set dysplastic ears, micrognathia, high arched palate, antimongoloid slant of palpebral fissures, epicanthic folds, bulbous nose, long philtrum, down-turned corners of the mouth, ulnar-derivate hands, arachnodactyly of fingers and toes; asymmetric thorax and head, scoliosis, joint contractures of hips; bilateral inguinal hernia, moderate hydrocephalus, bilateral sensor neural hearing loss, delayed psychomotor development + mental retardation; postnatal growth >95. percentile |
||||||||||
| 15-N- qt24~ 25/ 1-1 |
female/ 3y |
PBL | de novo | 47,XX,+mar[10]/ 46,XX[10] |
inv dup(15)(qter→q24~25: :q24~25→qter) | M-FISH; MCB | see below | {0} provided by Dr. Polityko, Minsk, Belarus | ||
|
multiple congenital malformations |
||||||||||
| 15-N- qt25/ 1-1 |
female/ 1w |
PBL | de novo | 47,XX,+mar[20] | inv dup(15)(qter→q25: :q25→qter) | not nearer specified cep probes; SKY | see below | {112; 144; 167; 244} | ||
|
child born at term, normal weight and length; flattened nasal tip; abnormal ears, facial asymmetry, thin upper lip, long philtrum, labia majora hypoplastic, incomplete hip abduction, hypotonic, aortic arch hypoplasia, severe coarctation of aorta, moderate VSD, Dandy-Walker variant in brain; severe hearing loss, child died at 12d. |
||||||||||
| 15-N- qt25/ 1-2 |
male/ 1w |
PBL | de novo | 47,XY,+mar[79%]/ 46,XY[21%] |
inv dup(15)(qter→q25: :q25→qter) | wcp15; wcp20; FES-specific probe (15q25-qter) | see below | {115; 144; 167; 244} | ||
|
child born at week 29 due to spontaneous rupture of membranes; bilateral hydronephrosis in ultrasound; weight 1530g (50.-90. centile), length 44cm (>90. centile), OFC 26.5cm (10.-50. centile); APGAR 3/6/10; no spontaneous respiration; turricephaly with metopic ridge; blepharophimosis, high and broad nasal bridge, small mouth, micrognathia, bilateral cup-shaped ears, long fingers and toes, overlapping toes 2over 1 and 4 over5; atrial-septal defect, open ductus arteriousus hydronephrosis of right kidney; child died at 1m |
||||||||||
| 15-N- qt25/ 1-3 |
female/ 2y2m |
PBL/ Fibroblasts | de novo | 47,XX,+mar[14] at 2y at 10y in PBL: mar in 10/20 in fibroblasts: mar in 11/60 |
inv dup(15)(qter→q25: :q25→qter) sSMC derived from maternal chromosome 15 |
pan-centromeric probe, cep15; wcp15; SNRPN, PML probes; UPD-test | see below | {122; 144; 167; 244} | ||
|
child born with normal weight but length >97. centile, ptosis, epicanthal folds, elbow contractures, four-vessel cord, unusual hands and feet; hypoplastic labia majora; no immediate problems at newborn period; At 95. centile length <95. centile, weight at 10. centile, OFC ~90. centile; developmental delay; At 10y height >97. centile, weight at 75. centile, OFC ~90. centile; myopathic facial expression; upslanting eyebrows, bilateral ptosis, down slanting palpebral fissures; abnormal ears; high arched palate, micrognathia, hypomelanosis of Ito; moderate to severe mental retardation. |
||||||||||
| 15-N- qt25/ 1-4 |
male/ postnatal |
PBL | de novo | 47,XY,inv(9)(p11q13),+mar[40]/ 46,XY,inv(9)(p11q13)[10] |
inv dup(15)(qter→q25: :q25→qter) sSMC derived from paternal chromosome 15 |
M-FISH; SKY; different FISH-probes as given in ref 181; CGH; UPD-test |
see below |
{181; 183; 244} | ||
|
Born by caesarean section at 37 weeks of pregnancy; pregnancy was complicated by mild bleeding that resolved spontaneously in the first trimester. Presentation was breech. At birth, APGAR 7 and 9, at 1 and 5 min, respectively. weight and length were 3275 g (50th percentile) and 51 cm (50th75th percentile), respectively; his OFC was 33.56 cm (25th percentile). Dysmorphic: cranium was asymmetric, with overlapping of the frontal bone over the parietals, a prominent metopic suture, and a very small anterior fontanel; long face with a prominent, bulbous nose, and microretrognatia. Finger and toes were long. Both hands with finger contractures of second through fourth fingers and extension of the fifth finger, in a position reminiscent of trisomy 18; hypotonic and initially sucked poorly. At 3 months, generally in good health, showed mild developmental delay, and altered muscular tone (hypertonia of lower limbs and hypotonia of upper limbs). weight 6990 g (85th percentile), length 66.5 cm (>95th percentile), and OFC 41.5 cm (55th percentile); strabismus and a left epicanthic fold; ears small and low-set, nasal bridge wide, nipples hypoplastic, and a hydrocele was noted; sacral pilonidal sinus and hypoplastic toenails; audiogram → bilateral sensor neural hearing loss. At 7 months, weight (9360 g) and length (76 cm) are at 85th and 97th percentile, respectively, OFC 45.6cm (75th percentile). He is alert and responsive but did not roll over. |
||||||||||
| 15-N- qt25.2- 25.3/ 1-1 |
n.a./ postnatal |
PBL | de novo | 47,+mar[?]/ 46,[?] |
inv dup(15)(qter→q25.3: :q25.2→qter) | BAC probes as given in ref 166 |
see below |
{166}case 2 {167; 244} |
||
|
Birth: at term; weight 3200 g; length 47 cm. At the age of 18:weight 55 kg, height 152 cm, lower limb asymmetry, bilateral palpebral ptosis, hyperlaxity of connective tissue, speech delay, mild mental retardation. |
||||||||||
| 15-N- qt25.3/ 1-1 |
female/ 1w |
PBL | de novo | 47,XX,+mar[82%]/ 46,XX[18%] |
inv dup(15)(qter→q25.3: :q25.3→qter) | alpha-, beta-satellite satIII telomeric, all wcp, YAC-probes (not specified) | mental retardation and/or developmental delay or structural anomalies detected at birth | {111} case 1 {116; 144; 167; 244} |
||
| 15-N- qt25.3/ 1-2 |
male/ 1w |
PBL | de novo | 47,XY,+mar[74%]/ 46,XY[26%] |
inv dup(15)(qter→q25.3: :q25.3→qter) sSMC derived from paternal chromosome 15 |
alpha-, beta-satellite satIII telomeric, all wcp, YAC-probes (not specified); UPD-test | mental retardation and/or developmental delay or structural anomalies detected at birth | {111} case 2 {116; 144; 167; 244} |
||
| 15-N- qt25.3/ 1-3 |
female/ 4.5y |
PBL | de novo | 47,XX,+mar[19]/ 46,XX[1] |
inv dup(15)(qter→q25.3: :q25.3→qter) | CGH, wcp15, SNRPN, PML, FES, D15Z, pan-centromeric probe | see below | {127; 144; 167; 244} | ||
|
birth weight , length and weight >75., >95. and >95. centile; macrodolichocephaly, hypotonic, fingers with camptodactyly, strabismus, overgrowth with weight and length >95. centile; facial scoliosis, developmental delay, Wilms tumor at 4y; |
||||||||||
| 15-N- qt25.3/ 1-4 |
male/ prenatal |
AF | de novo | 47,XY,+mar[20]/ 46,XY[1] repeat analysis: mar in 28 of 36 cord blood: mar in 28 of 40 liver: mar in 13 of 40 lung: mar in 14 of 40 skin: mar in 27 of 40 placenta: mar in 0 of 40 umbilical cord: mar in 40 of 40 |
inv dup(15)(qter→q25.3: :q25.3→qter) sSMC derived from maternal chromosome 15 |
cep 15; subtel 15q, SKY, QF-PCR; UPD-test | see below | {161; 244} | ||
|
Amniocentesis due to advanced maternal age; TOP at week 22; autopsy showed dysmorphic features of asymmetry of the head, broad nasal bridge, bulbous nose, low set ears, long philtrum, micrognathia, slender fingers and toes, overlapping toes; horseshoe kidney, pulmonary hypoplasia |
||||||||||
| 15-N- qt26.1/ 1-1 |
male/ 1w |
PBL | de novo | 47,XY,+mar[86%]/ 46,XY[14%] |
inv dup(15)(qter→q26.1: :q26.1→qter) | alpha-, beta-satellite satIII telomeric, all wcp, YAC-probes (not specified); UPD-test | mental retardation and/or developmental delay or structural anomalies detected at birth | {111} case 3 {116; 144; 167; 244} |
||
| 15-N- qt26.1/ 1-2 |
male/ prenatal |
AF/ chord blood |
de novo | 47,XY,+mar[29]/46,XY[1] 47,XY,+mar[43]/46,XY[22] |
inv dup(15)(qter→q26.1: :q26.1→qter) | midi, centromeric probes, wcp | see below | {172; 173; 177; 244} | ||
|
Ultrasound normal in week 18; amniocentesis due to advanced maternal age; born after spontaneous labor at 29 weeks gestation. Birth weight 1940g (60th centile), length 44cm (50th centile), head circumference 31.2cm (above 60th centile); dysmorphic features: short palpebral fissures, broad and flat nasal bridge; telecanthus, high forehead, micrognathia ears low-set and posteriorly rotated with over folded helices, long and thin feet, fifth-finger nail hypoplasia, clinodactyly, scrotum under-developed and testes were undescended bilaterally; chest X-ray →only eleven ribs, bilateral corneal dystrophy; on day three of life, renal failure. Death on day five. |
||||||||||
N-Cases with similar imbalances NOT caused by sSMC (N-IMB)
| case no. | gender/ age at diagnosis | studied material |
de novo/ inherited |
GTG-banding result and FISH result incl. grade of mosaicism | test methods |
clinical symptoms | reference | ||
|
15-N- |
see {268} |
{268} |
|||||||
|
15-N- |
n.a./ |
n.a. |
n.a. |
46,trp(15)(q24q26) |
n.a. |
congenital anomalies |
{247} |
||
| 15-N- IMB- q24.3/ 1-1 |
male/ 23y |
PBL | de novo | 46,XY,trp(15)(pter→qter: :qter→q24.3::q23.3→qter)[68%]/ 46,XY,der(3)t(3;15)(15qter→→.3: :15q24.3→15qter: :3pter→3qter)[7%]/ 46,XY[25%] triplication derived from paternal chromosome 15 |
different FISH-probes and BACs; UPD-test | see below | {219} | ||
|
Born at 37 weeks gestation with loop of umbilical cord and APGAR scores 4, 7, and 10 at 1, 5, and 10 min. Birth weight 2,810 g (10th-5th centile), length 51 cm (50th-90th centile). Facial dysmorphism and left body hemihypertroph; psychomotor development delayed. Cerebral tomography at 1 year old: ventricular dilatation and septum lucidum cyst. At 6 years: he underwent treatment for left Wilm’s tumor (stage II) including left nephrectomy, chemotherapy, and irradiation. He had two fractures of the left femur at 17 years old. At 23 years: weight 43 kg, height 162 cm (underestimated because of a severe scoliosis), head circumference 56 cm. Face and body were asymmetrical, with left hemi-hypertrophy. Dysmorphic features: up-slanting palpebral fissures, strabismus, long pyramidal nose, short philtrum, retrognathism and low-set, small and squared right ear with a thick helix. Fingers thin and long, toes stocky with bilateral hallux valgus. Other features: severe scoliosis, asymmetry of lower limbs, numerous naevi, developmental delay with sociable behavior and hearing loss. |
|||||||||
| 15-N- IMB- q25.2/ 1-1 |
male/ 4y8m |
PBL | de novo | 46,XY,der(15)(qter→q25.2: :p11.1→qter) |
different FISH-probes wcp 15 and BACs | see below | {230} | ||
|
Delivery with caesarean section because of dystocia and reduction of cardiac rate for a few minutes. Birth after 39 weeks of gestation, weight 2.750 g (10th centile), length 50 cm (>25th centile), OFC 32 cm (<3rd centile). APGAR 7 and 10. At birth congenital bilateral strabismus. Developmental delay; did not walk until 18-20 months, no speech at ~5y. At 4y 8m severe language delay and behavioral problems (hyperactivity, motor stereotypes, social isolation); no relevant dysmorphic features except prominence of metopic sutures and he seemed older than his chronological age and bone age equivalent to that of a 7-year-old boy. Occipitofrontal circumference 52 cm (50-75th centile), weight 22.300 g, height 118 cm (at and above the 97th centile). He was clumsy with deficits noted in fine motor coordination. He was toilet trained. In routine blood analysis slight anemia with microcytosis. Brain MRI scan 0.5 T images showed a supratentorial widening of the ventricular system and a slight asymmetry, with irregular outline of lateral ventricles. A minor brain malformation, i.e., a thin corpus callosum and hypotrophic shortened hippocampi with slight asymmetry of the cerebellar tonsils, the right one slightly overhanging the foramen magnum, was seen. He met the criteria for classic autism in all the three main domains which are usually considered, i.e., communication, reciprocal social interactions and behavior. At 4 years and 9 months he experienced his first seizure, characterized by localized motor phenomena (left arm myoclonic jerks and deviation of gaze and head to the right) followed by generalized tonic clonic activity. |
|||||||||